Taken together, these findings further delineate the pathway through which Mtb infection triggers HO-1 expression while demonstrating the potential use of the enzyme as biomarker for disease and treatment outcome in the complex setting of a population where TB and HIV-1 infections coexist. This evidence concerns the gene HMOX1 and HIV-1 infection.